Aldeyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALDX)

CUSIP: 01438T106

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-1,196,576
Put/Call ratio
51%
SEC-reported price per share
$1.69
Number of holders
127
Value change
-$20,444,263
Number of buys
70
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,596,036

Security key

01438T106

Report period

Q1 2026

Institutions

127

Top holders

10

Ownership snapshot

Top reported holders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
Knoll Capital Management,...
Comparable rows
0/15
Latest evidence
31 Dec 2025
3/4/5 13F Highest disclosed value: $28,363,172 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Knoll Capital Management, LLC has the largest disclosed position value at $28.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Knoll Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $27.83M
Knoll Capital Management, LLC $28.36M
BlackRock, Inc. $19.94M
VANGUARD GROUP INC $19.16M
KINGDON CAPITAL MANAGEMENT, L.L.C. $9.58M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$27,829,793
5,875,851 shares
— 03 Apr 2025
Knoll Capital Management, LLC
13F
Company
13F
—
denominator unverified
$28,363,172
5,475,516 shares
— 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$19,943,533
3,850,103 shares
— 31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$19,159,173
3,698,682 shares
— 31 Dec 2025
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
denominator unverified
$9,583,000
1,850,000 shares
— 31 Dec 2025
D. E. Shaw & Co., Inc.
13F
Company
13F
—
denominator unverified
$8,294,858
1,601,324 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
127
Shares
37,269,714
Rows available
127
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
127
Q1 2026 holders
127
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .